Arrhythmogenic right ventricular cardiomyopathy (ARVC/D)

A systematic literature review

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetic form of cardiomyopathy (CM) usually transmitted with an autosomal dominant pattern. It primary affects the right ventricle (RV), but may involve the left ventricle (LV) and culminate in biventricular heart failure (HF), life threatening ventricular arrhythmias and sudden cardiac death (SCD). It accounts for 11%-22% of cases of SCD in the young athlete population. Pathologically is characterized by myocardial atrophy, fibrofatty replacement and chamber dilation. Diagnosis is often difficult due to the nonspecific nature of the disease and the broad spectrum of phenotypic variations. Therefore consensus diagnostic criteria have been developed and combined electrocardiography, echocardiography, cardiac magnetic resonance imaging (CMRI) and myocardial biopsy. Early detection, family screening and risk stratification are the cornerstones in the diagnostic evaluation. Implantable cardioverter-defibrillator (ICD) implantation, ablative procedures and heart transplantation are currently the main therapeutic options.

Original languageEnglish (US)
Pages (from-to)97-114
Number of pages18
JournalClinical Medicine Insights: Cardiology
Volume7
DOIs
StatePublished - May 21 2013

Fingerprint

Arrhythmogenic Right Ventricular Dysplasia
Sudden Cardiac Death
Heart Ventricles
Implantable Defibrillators
Heart Transplantation
Cardiomyopathies
Athletes
Atrophy
Echocardiography
Cardiac Arrhythmias
Dilatation
Consensus
Electrocardiography
Heart Failure
Magnetic Resonance Imaging
Biopsy
Population
Therapeutics

Keywords

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC/D)
  • Cardiomyopathy
  • Sudden cardiac death
  • Tachyarrhythmias

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{9690e1c0eaa44cca991f548247aaed71,
title = "Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): A systematic literature review",
abstract = "Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetic form of cardiomyopathy (CM) usually transmitted with an autosomal dominant pattern. It primary affects the right ventricle (RV), but may involve the left ventricle (LV) and culminate in biventricular heart failure (HF), life threatening ventricular arrhythmias and sudden cardiac death (SCD). It accounts for 11{\%}-22{\%} of cases of SCD in the young athlete population. Pathologically is characterized by myocardial atrophy, fibrofatty replacement and chamber dilation. Diagnosis is often difficult due to the nonspecific nature of the disease and the broad spectrum of phenotypic variations. Therefore consensus diagnostic criteria have been developed and combined electrocardiography, echocardiography, cardiac magnetic resonance imaging (CMRI) and myocardial biopsy. Early detection, family screening and risk stratification are the cornerstones in the diagnostic evaluation. Implantable cardioverter-defibrillator (ICD) implantation, ablative procedures and heart transplantation are currently the main therapeutic options.",
keywords = "Arrhythmogenic right ventricular cardiomyopathy (ARVC/D), Cardiomyopathy, Sudden cardiac death, Tachyarrhythmias",
author = "Romero, {Jorge E.} and Eeliany Mejia-Lopez and Manrique, {Carlos R.} and Lucariello, {Richard J.}",
year = "2013",
month = "5",
day = "21",
doi = "10.4137/CMC.S10940",
language = "English (US)",
volume = "7",
pages = "97--114",
journal = "Clinical Medicine Insights: Cardiology",
issn = "1179-5468",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Arrhythmogenic right ventricular cardiomyopathy (ARVC/D)

T2 - A systematic literature review

AU - Romero, Jorge E.

AU - Mejia-Lopez, Eeliany

AU - Manrique, Carlos R.

AU - Lucariello, Richard J.

PY - 2013/5/21

Y1 - 2013/5/21

N2 - Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetic form of cardiomyopathy (CM) usually transmitted with an autosomal dominant pattern. It primary affects the right ventricle (RV), but may involve the left ventricle (LV) and culminate in biventricular heart failure (HF), life threatening ventricular arrhythmias and sudden cardiac death (SCD). It accounts for 11%-22% of cases of SCD in the young athlete population. Pathologically is characterized by myocardial atrophy, fibrofatty replacement and chamber dilation. Diagnosis is often difficult due to the nonspecific nature of the disease and the broad spectrum of phenotypic variations. Therefore consensus diagnostic criteria have been developed and combined electrocardiography, echocardiography, cardiac magnetic resonance imaging (CMRI) and myocardial biopsy. Early detection, family screening and risk stratification are the cornerstones in the diagnostic evaluation. Implantable cardioverter-defibrillator (ICD) implantation, ablative procedures and heart transplantation are currently the main therapeutic options.

AB - Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetic form of cardiomyopathy (CM) usually transmitted with an autosomal dominant pattern. It primary affects the right ventricle (RV), but may involve the left ventricle (LV) and culminate in biventricular heart failure (HF), life threatening ventricular arrhythmias and sudden cardiac death (SCD). It accounts for 11%-22% of cases of SCD in the young athlete population. Pathologically is characterized by myocardial atrophy, fibrofatty replacement and chamber dilation. Diagnosis is often difficult due to the nonspecific nature of the disease and the broad spectrum of phenotypic variations. Therefore consensus diagnostic criteria have been developed and combined electrocardiography, echocardiography, cardiac magnetic resonance imaging (CMRI) and myocardial biopsy. Early detection, family screening and risk stratification are the cornerstones in the diagnostic evaluation. Implantable cardioverter-defibrillator (ICD) implantation, ablative procedures and heart transplantation are currently the main therapeutic options.

KW - Arrhythmogenic right ventricular cardiomyopathy (ARVC/D)

KW - Cardiomyopathy

KW - Sudden cardiac death

KW - Tachyarrhythmias

UR - http://www.scopus.com/inward/record.url?scp=84878195274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878195274&partnerID=8YFLogxK

U2 - 10.4137/CMC.S10940

DO - 10.4137/CMC.S10940

M3 - Article

VL - 7

SP - 97

EP - 114

JO - Clinical Medicine Insights: Cardiology

JF - Clinical Medicine Insights: Cardiology

SN - 1179-5468

ER -